label int64 1 1 | id stringlengths 10 12 | original_id stringlengths 8 9 | text stringlengths 347 29.5k |
|---|---|---|---|
1 | 170488305_0 | 170488305 | Form 20-F
Table of Contents
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 20-F
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC... |
1 | 170488305_1 | 170488305 |
Biotech plc (Exact name of Registrant as specified in its charter and translation of Registrant<U+0092>s name into English)
Ireland (Jurisdiction of
incorporation or organization) IDA Business Park, Bray, Co. Wicklow, Ireland
(Address of principal executive offices)
Kevin Tansley Chief
Financial Off... |
1 | 170488305_2 | 170488305 | pursuant to Section 12(g) of the Act: None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
Indicate the number of outstanding shares of each of the issuer<U+0092>s classes of capital or common stock as of the close of the period covered
by the annual report: ... |
1 | 170488305_3 | 170488305 |
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨ Indicate by check mark
whether the registrant has submitted electronically and posted on its... |
1 | 170488305_b0 | 170488305 |
Lease agreement dated as of February 13, 2012 between Barco Inv. Inc with Mardx Diagnostics in respect of office premises in San Diego, California, U.S.A.
4.17
Lease agreement dated as of December 1, 2007 between 60 Pineview LLC with Immco Diagnostics Inc in respect of office premises in Amherst, Ne... |
1 | 170488305_b1 | 170488305 | O<U+0092>Connell and Jim Walsh with Trinity Biotech plc in respect of warehouse premises in
Bray, Co Wicklow, Ireland (included as Exhibit 4b.2 to our to our Annual Report on Form 20-F (File No. 000- 22320), filed with the SEC on 31 March 2006).
4.13
Lease agreement dated as of December 20, 2007 between ... |
1 | 170492396_0 | 170492396 | Form 20-F
Table of Contents
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 20-F
(Mark One)
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES E... |
1 | 170492396_1 | 170492396 | 36815
Ascendis
Pharma A/S (Exact name of Registrant as specified in its charter and translation of Registrant<U+0092>s name into English)
The Kingdom of Denmark
(Jurisdiction of incorporation or organization)
Tuborg Boulevard 12
DK-2900 Hellerup, Denmark
(Address of principal executive office... |
1 | 170492396_2 | 170492396 | shares, nominal value DKK 1 per share*
The NASDAQ Stock Market LLC*
*
Not for trading, but only in connection with the registration of the American Depositary Shares.
Securities registered or to be registered pursuant to Section 12(g) of the Act: None
Securities for which there is a reporting obligation... |
1 | 170492396_3 | 170492396 | . ¨ Yes x No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject t... |
1 | 170492396_b0 | 170492396 |
Except for the information disclosed above, we have not undertaken any significant transactions with members
of the Board of Directors, the Executive Management or the major shareholders, or undertakings in which the identified related parties have significant interests.
Note 18<U+0097>Owner... |
1 | 170492396_b1 | 170492396 |
2014
2013
2012
(EUR<U+0092>000)
Board of Directors:
Purchase of services
0
(19
)
(71
)
Total transactions with rela... |
1 | 170492794_0 | 170492794 | Use these links to rapidly review the document TABLE OF CONTENTS voxeljet AG INDEX TO FINANCIAL STATEMENTS
Table of Contents
As filed with the Securities and Exchange Commission on March 26, 2015
UNITED STATES
... |
1 | 170492794_1 | 170492794 | TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2014
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
o
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC... |
1 | 170492794_2 | 170492794 | 111,
Address: Paul-Lenz Straße 1a, 86316 Friedberg, Germany(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities
registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class
Name of each exchang... |
1 | 170492794_3 | 170492794 | )
Securities
registered for which there is a reporting obligation pursuant Section 15(d) of the Act.
None(Title of Class)
Indicate
the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period... |
1 | 170492794_b0 | 170492794 | voxeljet AG. The calculation of earnings (loss) per share is adjusted retrospectively for all periods to reflect the number of voxeljet AG shares issued and
outstanding after the merger.
On
October 23, 2013, the Company's registration statement on Form F-1 (File No. 333-191526) of 7,475,000 American
... |
1 | 170492794_b1 | 170492794 | and a stated value of one Euro (EUR 1) and each shareholder owned the same proportionate interest as in Voxeljet
Technology GmbH.
Effective
September 12, 2013, the Voxeljet Technology GmbH was merged into VXLT 2013 AG upon registration of the merger in the commercial register of the surviving entity,
... |
1 | 170494675_0 | 170494675 | Form 20-F
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 20-F
(Mark One)
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF ... |
1 | 170494675_1 | 170494675 |
Commission file number 001-36153
Criteo S.A. (Exact name
of Registrant as specified in its charter and translation of Registrant<U+0092>s name into English)
France (Jurisdiction of
incorporation or organization) 32, rue Blanche, 75009 Paris<U+0097>France
(Address of principal executive office... |
1 | 170494675_2 | 170494675 | one
The Nasdaq Stock Market LLC
ordinary share, nominal value <U+0080>0.025 per share
Ordinary shares, nominal value <U+0080>0.025 per share*
The Nasdaq Stock Market LLC*
*
Not for trading, but only in connection with the registration of the American Depositary Shares.
Securities registered o... |
1 | 170494675_3 | 170494675 | x No ¨
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934. Yes ¨ No x
Indicate by check mark whether the registrant (1) has filed all reports required to be f... |
1 | 170494675_b0 | 170494675 |
Description
Schedule/Form
FileNumber
Exhibit
File
Date
4.15#<U+0086>
Employment Agreement between the registrant and Romain Niccoli, effective as of March 2006, and amendments thereto (English translation)
... |
1 | 170494675_b1 | 170494675 |
October 2, 2013
4.13<U+0086>
Employment Agreement between the registrant and
Eric Eichmann, effective as of March 2013, and related side letters
20-F
001-36153
1.1
March 6, 2014
4.14#<U+0086>
Employment Offer Letter between the registrant
a... |
1 | 170498601_0 | 170498601 | Form 10-K
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
x
ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended: December 31, 2014
¨
TRANSITION REPORT UN... |
1 | 170498601_1 | 170498601 | .)
309 Waverley Oaks Road, Suite 105, Waltham, MA 02452
(Address of principal executive offices)
Registrant<U+0092>s telephone number, including area code: (508) 653-3335
Securities registered pursuant to Section 12(b) of the Exchange Act: None
Securities registered pursuant to Section 12(g) of the Exchange Act... |
1 | 170498601_2 | 170498601 | 2) has been subject to such filing requirements for the past
90 days. Yes ¨ No x
(Note: The registrant was a voluntary filer of reports under Section 15(d) of the Securities Exchange Act of 1934 until January 14, 2015, at which
time the registrant became a Section 15(d) filer; the registrant filed during th... |
1 | 170498601_3 | 170498601 | chapter) is not contained herein, and will not be contained, to the best of the registrant<U+0092>s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form
10-K. x Indicate by check mark whether the registrant is a large accelera... |
1 | 170498601_b0 | 170498601 |
13,400,708
13,885,396
15.
Restructuring Charge
During 2014, the Company initiated reductions in workforce to control costs while the Company pursued new financing alternatives. During
2014, the Company recorded $175 in restructuring charge... |
1 | 170498601_b1 | 170498601 | has net losses for each period presented. The following common stock
equivalents were excluded from the calculation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:
View the table below in Excel
... |
1 | 170501599_0 | 170501599 | 10-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
(Mark One)
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2014
or
¨
TRANSITION REPORT PURSUANT TO SEC... |
1 | 170501599_1 | 170501599 | Baggot Street Lower
Dublin 2 Ireland (Address
of principal executive offices, including zip code) Registrant<U+0092>s Telephone Number, Including Area Code:
+353 (1) 659 9446
Securities registered pursuant to Section 12(b) of the Act:
Ordinary Shares, $0.001 Par Value
The NASDAQ Global Mark... |
1 | 170501599_2 | 170501599 | filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90
days. Yes ¨ No x
Indic... |
1 | 170501599_3 | 170501599 | . x Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of <U+0093>large accelerated filer,<U+0094> <U+0093>accelerated filer<U+0094> and <U+0093>smaller reporting company<U+0094> in 12b-2 of the Exc... |
1 | 170501599_b0 | 170501599 |
Consent of Deloitte & Touche, LLP, Independent Registered Public Accounting Firm.
24.1+
Power of Attorney (included on the signature page)
31.1+
Certification of Chief Executive Officer of Presbia PLC pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
31.2+
... |
1 | 170501599_b1 | 170501599 |
Sublease, dated May 6, 2014, by and between Trustwave Holdings, Inc. and PresbiBio, LLC
10.11(3)
First Amendment to Sublease, dated July 16, 2014, by and between Trustwave Holdings, Inc. and PresbiBio, LLC
10.12(3)
Form of Indemnification Agreement between Presbia USA, Inc. and its officers and ... |
1 | 170508377_0 | 170508377 | f20f_040215.htm
As filed with the Securities and Exchange Commission on April 2, 2015
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
o REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934,
OR
... |
1 | 170508377_1 | 170508377 | requiring this shell company report_________________________
000-29374
(Commission file number)
EDAP TMS S.A.
(Exact name of registrant as specified in its charter)
France
(Jurisdiction of incorporation or organization)
Parc d’Activites la Poudrette-Lamartine
4/6, rue du Dau... |
1 | 170508377_2 | 170508377 | b) of the Act:
Title of each class
Name of each exchange on which registered
American Depositary Shares, each representing
NASDAQ Global Market
One Ordinary Share
Ordinary Shares, nominal value €0.13 per share
NASDAQ Global Market
Securities registered or to be... |
1 | 170508377_3 | 170508377 | the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes _____No__X__
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act ... |
1 | 170508377_b0 | 170508377 | thousand. As of December 31, 2013, receivables from Dae You amounted to €423 thousand.
30—SUBSEQUENT SIGNIFICANT EVENTS
a) On January 9, 2015, our Focal One HIFU device was approved by Health Canada which will allow us to market the Focal One device for the treatment of prostate cancer in Canada.
... |
1 | 170508377_b1 | 170508377 |
236
64
137
29—RELATED PARTY TRANSACTIONS
The General Manager of the Company's Korean branch "EDAP-TMS Korea" is also Chairman of a Korean company named Dae You. EDAP-TMS Korea subcontracts to Dae You the service contract maintenance of our medical devices installed in Korea... |
1 | 170516194_0 | 170516194 | Use these links to rapidly review the document TABLE OF CONTENTS UNIQURE N.V. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
Table of Contents
SECURITIES AND EXCHANGE COMMISSIONWashington D.C. 20549
... |
1 | 170516194_1 | 170516194 | 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2014
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period
from to
... |
1 | 170516194_2 | 170516194 |
Jörn Aldag
Chief Executive Officer
Tel: +31 20 240-6000
Meibergdreef 61, 1105BA Amsterdam, The Netherlands(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities
registered or to be registered pursuant to Section 12(b) of the Act:
Title o... |
1 | 170516194_3 | 170516194 |
(as of December 31, 2014)
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
o Yes ý No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Sectio... |
1 | 170516194_b0 | 170516194 | ate with BMS in the preparation of all regulatory materials and interactions with regulatory authorities. BMS will be
responsible for clinical development and all commercial activities across all programs.
The
financial terms consist of guaranteed, near-term payments to uniQure of at least $97 million, ... |
1 | 170516194_b1 | 170516194 | . We are required to
make payments for pre-clinical, clinical and regulatory milestones under this collaboration as well as low single digit royalties.
On
April 6, 2015, the Company entered into agreements with BMS, which provide BMS exclusive access to uniQure's gene therapy technology platform for m... |
1 | 170521780_0 | 170521780 | 20-F
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 20-F
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES... |
1 | 170521780_1 | 170521780 | 001-35408
AVG
TECHNOLOGIES N.V. (Exact name of Registrant as specified in its charter and translation of Registrant<U+0092>s name into English)
The Netherlands
(Jurisdiction of incorporation or organization)
Gatwickstraat 9-39, 1043
GL Amsterdam, The Netherlands
(Address of principal execut... |
1 | 170521780_2 | 170521780 | of outstanding shares of each of the issuer<U+0092>s classes of capital or common stock as of the close of the period covered
by the annual report.
Title of each class
Number of shares outstanding
Ordinary shares
51,641,505
Indicate by check mark if the registrant is a well-known seasoned ... |
1 | 170521780_3 | 170521780 | of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past
90 days. x Yes ¨ No
Indicate by check mark whether the registrant has submitted electron... |
1 | 170521780_b0 | 170521780 |
1.16
$
1.02
The following securities that could potentially dilute basic earnings per share in the future have been
excluded from the above computation of earnings per share as their inclusion would have been anti-dilutive.
View the table below in Excel
... |
1 | 170521780_b1 | 170521780 |
Weighted-average ordinary shares outstanding <U+0096> diluted
54,308,518
54,710,704
52,591,435
Earnings per share attributable to AVG Technologies N.V. ordinary ... |
1 | 170522944_0 | 170522944 | 20-F
Table of Contents
SECURITIES AND EXCHANGE
COMMISSION Washington, D.C. 20549
FORM 20-F
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 193... |
1 | 170522944_1 | 170522944 |
CGG
(Exact name of registrant as specified in its charter)
CGG
(Translation of registrant<U+0092>s name into English)
Republic of France (Jurisdiction of incorporation or organization) Tour Maine
Montparnasse 33, avenue du Maine 75015 Paris France (Address of principal executive
offices) Stephan... |
1 | 170522944_2 | 170522944 | per share
New York Stock Exchange
Securities registered or to be registered pursuant to Section 12(g) of the Act.
None
(Title of class) Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act. 7.75% Senior Notes due 2017 6.50% Senior Notes due 2021
6.875% Senior Notes d... |
1 | 170522944_3 | 170522944 | of
1934. Yes ¨ No x Note <U+0097> checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those
sections. Indicate by check mark whether the registrant has submitted electronically and... |
1 | 170522944_b0 | 170522944 |
<U+0097>
17.7
17.7
Cash at opening
340.8
89.5
8.3
92.8
<U+0097>
... |
1 | 170522944_b1 | 170522944 |
(487.5
)
(62.9
)
(368.1
)
146.8
(744.6
)
Cash flow from financing activities
348.9
390.4
(3.8
)
(270.2
)
329.5
794.8
Effect of exchange rates on cash
<U... |
1 | 170534180_0 | 170534180 | 20-F
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
þ
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANG... |
1 | 170534180_1 | 170534180 | 1-35135
SEQUANS COMMUNICATIONS S.A.(Exact name of Registrant as specified in its charter)
Not Applicable (Translation of Registrant<U+0092>s name into English) French Republic
(Jurisdiction of incorporation or organization)
15-55 Boulevard Charles de Gaulle 92700 Colombes, France (Address of principal ex... |
1 | 170534180_2 | 170534180 | York Stock Exchange
ordinary share, nominal value <U+0080>0.02 per
share Ordinary shares, nominal value <U+0080>0.02 per
share
New York Stock Exchange*
*
Not for trading, but only in connection with the registration of American Depositary Shares.
Securities registered or to be registered pursu... |
1 | 170534180_3 | 170534180 | of the Securities
Act. ¨ Yes þ No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes ¨ No þ
Indicate by check mark whether the registrant (1) has fil... |
1 | 170534180_b0 | 170534180 | On June 26, 2014, the Board used this
authorization to make such grants with an exercise price of $1.77 per ordinary share. The board members were required to subscribe to the
warrants at a price of <U+0080>0.01 per warrant, as required by French law. There is no subscription required for founders warrants.
Share... |
1 | 170534180_b1 | 170534180 | members of the Board of Directors during the years ended December 31, 2012, 2013 and 2014: - On June 26, 2012, the shareholders authorized the Board of Directors to grant to Messrs. de Pesquidoux, Patterson, Pitteloud, Sharma and Slonimsky 6,000 warrants each and to Mr. Delfassy
25,000 warrants. On June 26, 2012, th... |
1 | 170537312_0 | 170537312 | Form 20-F
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
ANNUAL REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2014
Commission file number 001-36622
April ... |
1 | 170537312_1 | 170537312 | mail and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange on which registered
Ordinary Shares, nominal value <U+0080> 0.04 per share
NASDAQ Stock Mark... |
1 | 170537312_2 | 170537312 | the Securities Act.
¨ Yes x No If this report is an annual or transition report, indicate by check mark if the registrant is
not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. ¨ Yes x No
Note <U+0096> Checking the box above will not rel... |
1 | 170537312_3 | 170537312 | to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was
required to submit and post such files).
x Yes
¨ No Indicate by check mark whether the registrant is a large accelerated... |
1 | 170537312_b0 | 170537312 | +0096>December 31, 2012
(<U+0080> in thousands)
Audit fees
390
30
7
Audit-related fees
<U+0097>
<U+0097>
<U+0097>
Tax fees
<U+0097>
<U+0097>
<U+0097... |
1 | 170537312_b1 | 170537312 | +0093>Stichting ProQR Therapeutics Participation<U+0094>, which was a related
party, because Daniel de Boer, our chief executive officer and member of the Company<U+0092>s management board, was also chairman of the Foundation. On September 23, 2014, the loan was terminated against transfer of the treasury shares to th... |
1 | 170544077_0 | 170544077 | UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 20-F
View the table below in Excel
(Mark One)
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
ORx
ANN... |
1 | 170544077_1 | 170544077 | OF 1934
Date of event requiring this shell company report
For the transition period from to .
Commission file number: 001-36535
GLOBANT S.A.
(Exact name of Registrant as specified in its
charter)
... |
1 | 170544077_2 | 170544077 | and Address of Company Contact Person)
Securities registered or to be registered
pursuant to Section 12(b) of the Act.
Title of
each class
Name of
each exchange on which registered
Common shares, nominal value $1.20 per share
... |
1 | 170544077_3 | 170544077 | 603,900 common shares.
Indicate by check mark
if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.¨ Yes x No
If this report is an annual
or transaction report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or... |
1 | 170544077_b0 | 170544077 | equal to 10% of the Company’s issued share capital. If the legal reserve subsequently falls below the 10%
threshold, at least 5% of net profits again must be allocated toward the reserve. If the legal reserve exceeds 10% of the Company’s
issued share capital, the legal reserve may be reduced. The legal reserve is no... |
1 | 170544077_b1 | 170544077 | s Colombian subsidiary must appropriate at least 10% of net income for the year to a legal reserve, until
such reserve equals 50% of its respective capital stock amount. As of December 31, 2014, there was a legal reserve of 0.4 that
was fully constituted.
Under Spanish law, Globant
Spain must appropriate 10%... |
1 | 170551707_0 | 170551707 | 20-F
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 20-F
(Mark One)
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH... |
1 | 170551707_1 | 170551707 |
Commission file number 001-36153
DBV
TECHNOLOGIES S.A. (Exact name of Registrant as specified in its charter and translation of Registrant<U+0092>s name into English)
France (Jurisdiction of
incorporation or organization) Green Square-Bâtiment D
80/84 rue des Meuniers
92220 Bagneux France
... |
1 | 170551707_2 | 170551707 |
Title of each class
Name of each exchange on which registered
American Depositary Shares, each representing one-half of one ordinary share, nominal value <U+0080>0.10 per share
The Nasdaq Stock Market LLC
Ordinary shares, nominal value <U+0080>0.10 per share*
The Nasdaq Stock Market L... |
1 | 170551707_3 | 170551707 | Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ¨ Yes x No If this
report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchan... |
1 | 170551707_b0 | 170551707 |
10.7
09/22/14
8.1#
List of subsidiaries of the registrant
12.1#
Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-... |
1 | 170551707_b1 | 170551707 | English translation)
Form F-1
333-198870
10.4
09/22/14
4.7<U+0086>
2012, 2013 and 2014 Free Share Plans (English translation)
Form F-1
333-198870
10.5
09/22/14
4.8<U+0086>
Summary of BSA
Form F-1
333-... |
1 | 170554837_0 | 170554837 | UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 20-F
View the table below in Excel
<U+2610>
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
þ
ANNUAL REPORT PURSUANT TO... |
1 | 170554837_1 | 170554837 | ____________
OR
<U+2610>
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
COMMISSION FILE NUMBER:
001-35052
Adecoagro S.A.
(Exact name of Registrant
as specified in its charter)... |
1 | 170554837_2 | 170554837 | ,
L - 2453 Luxembourg
Email: abdelhakim.chagaar@intertrustgroup.com
Tel: +352.2644.9372
(Name, Telephone, E-Mail
and/or Facsimile number and Address of Company Contact Person)
Securities registered
or to be registered pursuant to Section 12(b) of the Act:
Title of Each Class
Name of Each E... |
1 | 170554837_3 | 170554837 | a well-known seasoned issuer, as defined in Rule 405 of the Securities Act
Yes <U+2610> No
þ
If this report is an annual
or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934.
Yes <U+2610> ... |
1 | 170554837_b0 | 170554837 | -
(402
)
Sales of goods
2,824
-
-
-
-
Services
70
... |
1 | 170554837_b1 | 170554837 |
CHS Agro
Joint venture
Purchases of goods
-
402
-
-
-
Payables (Note 20)
-
... |
1 | 170555404_0 | 170555404 | Form 20-F
Table of Contents
Natuzzi S.p.A
Annual Report on Form 20-F 2014
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the... |
1 | 170555404_1 | 170555404 | natuzzi.com; Via Iazzitiello 47, 70029 Santeramo in Colle, Bari, Italy
(Name, telephone, e-mail and/or facsimile number and address of company contact person)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange on which regi... |
1 | 170555404_2 | 170555404 | As of December 31, 2014 54,853,045 Ordinary Shares
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined
in Rule 405 of the Securities Act. Yes ¨ No x
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports ... |
1 | 170555404_3 | 170555404 | -T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a
non-accelerated filer. See definition of ... |
1 | 170555404_b0 | 170555404 | A. with the Securities and Exchange Commission
on June 30, 2008, file number 001-11854).
2.1
Deposit Agreement dated as of May 15, 1993, as amended and restated as of December 31, 2001, among the Company, The Bank of New York, as Depositary, and owners and beneficial owners of ADRs (incorporated by referenc... |
1 | 170555404_b1 | 170555404 |
Table of Contents
SIGNATURE
The registrant, Natuzzi S.p.A., hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and
authorized the undersigned to sign this annual report on its behalf.
NATUZZI S.p.A.
By
/s/ Pasquale Natuzzi
... |
1 | 170556572_0 | 170556572 | UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C. 20549
FORM 20-F
¨
REGISTRATION
STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
x
ANNUAL REPORT
... |
1 | 170556572_1 | 170556572 | REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
¨
SHELL
COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring
this shell company report_______________
For the t... |
1 | 170556572_2 | 170556572 | iction of incorporation
or organization)
Parc Club du Moulin à
Vent
33, avenue du Docteur
Georges Levy
69200 Vénissieux
France
(Address of principal
executive offices)
Phillandas T. Thompson
Senior Vice President and
General Counsel
Parc Club du Moulin à
Vent
33, aven... |
1 | 170556572_3 | 170556572 | inary Shares, nominal value 0.122 Euros per share, represented by
American Depositary Shares (as evidenced by American Depositary Receipts), each representing one Ordinary Share
NASDAQ Global Market
Securities registered or to be registered pursuant
to Section ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.